NEW THERAPIES
Despite the therapeutic options available, new therapy research solutions should regularly be investigated when dealing with people living with type 2 diabetes who also have heart failure (HF).1a,2a
One group of medicines that form part of the four pillars of treating people living with type 2 diabetes is SGLT-2 inhibitors. Since people living with type 2 diabetes are at high risk of developing or have, an established cardiovascular disease (CVD), SGLT2-2...